Balyasny Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Balyasny Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,620,879	Closed	-$68.3M	–	2869
2023 Q2	$68.3M	Buy	1,620,879 +863,267	+114%	+$34.9M	0.15%	174
2023 Q1	$27M	Buy	757,612 +756,940	+112,640%	+$27.5M	0.07%	422
2022 Q4	$24.6K	Sell	672 -256,643	-100%	-$10.1M	﹤0.01%	2455
2022 Q3	$12.1M	Buy	257,315 +234,716	+1,039%	+$15.2M	0.04%	598
2022 Q2	$1.62M	Sell	22,599 -26,378	-54%	-$1.93M	0.01%	1522
2022 Q1	$3.96M	Sell	48,977 -15,603	-24%	-$1.32M	0.01%	1050
2021 Q4	$6.63M	Sell	64,580 -36,498	-36%	-$3.5M	0.02%	756
2021 Q3	$8.84M	Sell	101,078 -207,915	-67%	-$18.8M	0.04%	625
2021 Q2	$27.7M	Buy	308,993 +112,720	+57%	+$9.52M	0.13%	209
2021 Q1	$14.9M	Buy	+196,273	New	+$14.8M	0.07%	369
2020 Q3	–	Sell	-92,075	Closed	-$5.48M	–	1676
2020 Q2	$5.36M	Sell	92,075 -35,711	-28%	-$1.92M	0.05%	502
2020 Q1	$5.04M	Sell	127,786 -38,314	-23%	-$2.24M	0.06%	401
2019 Q4	$9.88M	Buy	+166,100	New	+$8.93M	0.06%	434
2019 Q1	–	Sell	-21,954	Closed	-$864K	–	1729
2018 Q4	$864K	Sell	21,954 -71,532	-77%	-$3.32M	0.01%	942
2018 Q3	$4.82M	Buy	93,486 +30,057	+47%	+$1.47M	0.02%	712
2018 Q2	$2.98M	Sell	63,429 -82,819	-57%	-$3.43M	0.01%	811
2018 Q1	$5.19M	Sell	146,248 -1,530,634	-91%	-$60M	0.02%	698
2017 Q4	$73.1M	Buy	+1,676,882	New	+$78.3M	0.23%	100
2017 Q2	–	Sell	-898,161	Closed	-$41.2M	–	1832
2017 Q1	$41.2M	Buy	898,161 +843,807	+1,552%	+$42M	0.19%	131
2016 Q4	$2.86M	Buy	+54,354	New	+$2.63M	0.02%	823
2016 Q3	–	Sell	-12,772	Closed	-$487K	–	1334
2016 Q2	$487K	Buy	12,772 +3,957	+45%	+$174K	﹤0.01%	829
2016 Q1	$363K	Sell	8,815 -15,360	-64%	-$633K	﹤0.01%	960
2015 Q4	$1.17M	Sell	24,175 -140,399	-85%	-$6.25M	0.01%	696
2015 Q3	$6.58M	Buy	+164,574	New	+$7.19M	0.05%	453

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's SYNH Position: Q3 2023 in Review

Balyasny Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,620,879 shares — an estimated $68.3M sold.

Balyasny Asset Management first reported a position in SYNH in Q3 2015 and held it in 24 quarters. The position peaked at $73.1M in Q4 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Balyasny Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Balyasny Asset Management sold 1,620,879 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $68.3M.
Balyasny Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 24 quarters.
Balyasny Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $73.1M in Q4 2017.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.